ASX:NSB (Australia)
Â
Ordinary Shares
A$
0.05
(-7.69%)
Apr 26
Current and historical daily PE Ratio for Neuroscientific Biopharmaceuticals Ltd (
) from 2018 to Apr 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Neuroscientific Biopharmaceuticals stock (ASX:NSB) PE ratio as of Apr 26 2024 is 9.6.
More Details
Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) PE Ratio (TTM) Chart
Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Total 1105
- 1
- 2
- 3
- 4
- 5
- 6
- 13
| Neuroscientific Biopharmaceuticals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-26 | 9.6 | 2024-02-23 | 7.2 |
| 2024-04-26 | 9.6 | 2024-02-22 | 7.2 |
| 2024-04-24 | 10.4 | 2024-02-21 | 7.2 |
| 2024-04-23 | 10.6 | 2024-02-20 | 7.2 |
| 2024-04-22 | 10.4 | 2024-02-19 | 7.2 |
| 2024-04-19 | 10.6 | 2024-02-16 | 7.4 |
| 2024-04-18 | 11.8 | 2024-02-15 | 7.4 |
| 2024-04-17 | 11.8 | 2024-02-14 | 7.4 |
| 2024-04-16 | 11.6 | 2024-02-13 | 7.4 |
| 2024-04-15 | 12.2 | 2024-02-12 | 8.2 |
| 2024-04-12 | 12.0 | 2024-02-09 | 8.2 |
| 2024-04-11 | 12.6 | 2024-02-08 | 8.2 |
| 2024-04-10 | 13.2 | 2024-02-07 | 7.4 |
| 2024-04-09 | 13.2 | 2024-02-06 | 7.4 |
| 2024-04-08 | 12.4 | 2024-02-05 | 7.4 |
| 2024-04-05 | 13.0 | 2024-02-02 | 8.0 |
| 2024-04-04 | 13.2 | 2024-02-01 | 8.2 |
| 2024-04-03 | 12.0 | 2024-01-31 | 7.2 |
| 2024-04-02 | 11.0 | 2024-01-30 | 7.0 |
| 2024-04-01 | 9.4 | 2024-01-29 | 7.0 |
| 2024-03-29 | 9.4 | 2024-01-26 | 7.0 |
| 2024-03-28 | 9.4 | 2024-01-25 | 7.0 |
| 2024-03-27 | 9.6 | 2024-01-24 | 7.0 |
| 2024-03-26 | 9.6 | 2024-01-23 | 7.0 |
| 2024-03-25 | 9.0 | 2024-01-22 | 7.6 |
| 2024-03-22 | 9.8 | 2024-01-19 | 7.6 |
| 2024-03-21 | 9.4 | 2024-01-18 | 7.6 |
| 2024-03-20 | 10.4 | 2024-01-17 | 7.6 |
| 2024-03-19 | 9.4 | 2024-01-16 | 7.8 |
| 2024-03-18 | 9.4 | 2024-01-15 | 7.8 |
| 2024-03-15 | 9.6 | 2024-01-12 | 7.8 |
| 2024-03-14 | 9.2 | 2024-01-11 | 7.8 |
| 2024-03-13 | 9.4 | 2024-01-10 | 7.8 |
| 2024-03-12 | 10.2 | 2024-01-09 | 8.2 |
| 2024-03-11 | 8.6 | 2024-01-08 | 8.0 |
| 2024-03-08 | 8.4 | 2024-01-05 | 7.8 |
| 2024-03-07 | 8.6 | 2024-01-04 | 8.8 |
| 2024-03-06 | 8.6 | 2024-01-03 | 8.8 |
| 2024-03-05 | 9.0 | 2024-01-02 | 8.8 |
| 2024-03-04 | 8.4 | 2024-01-01 | 8.8 |
| 2024-03-01 | 9.2 | 2023-12-29 | 8.8 |
| 2024-02-29 | 9.6 | 2023-12-28 | 8.0 |
| 2024-02-28 | 7.4 | 2023-12-27 | At Loss |
| 2024-02-27 | 7.0 | 2023-12-22 | At Loss |
| 2024-02-26 | 7.0 | 2023-12-21 | At Loss |
Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Neuroscientific Biopharmaceuticals Ltd
ISIN : AU0000012973
Share Class Description:
ASX:NSB: Ordinary SharesDescription
Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers